These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1929448)

  • 21. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
    Suzuki K; Itaya S; Tsuge I; Matsuda T; Motai H; Kobayashi T; Shimada J; Baba S
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1349-54. PubMed ID: 8346933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on UFT concentration in tissues and serum of patients with malignant gynecologic tumors following oral administration].
    Ueda T; Kamiwatari M; Kosya S; Yamamoto S; Shiokawa H; Yamada E; Nagata Y
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2316-20. PubMed ID: 3111383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [UFT concentration in various tissues from cancer patients].
    Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of combination chemotherapy with topical application of 5-FU ointment to mice's tongue and UFT].
    Tateishi A; Sakaki Y; Kameyama Y; Hara I; Yamada N
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1877-85. PubMed ID: 2118335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of OK-432 on UFT activation].
    Yamamoto Y; Amano T; Imada T; Tamura S; Abe M; Matsumoto A
    Gan No Rinsho; 1988 May; 34(6):749-54. PubMed ID: 3132564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
    Une Y; Ito Y; Ogasawara K; Nagafuchi E; Matsuoka S; Misawa K; Sato N; Nakajima Y; Uchino J
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3153-9. PubMed ID: 2551251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I; Suzuki M; Tamada T; Nishida M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dynamic change of serum UFT concentration in a patient with tongue cancer complicating chronic renal failure].
    Yanagisawa T; Arimoto T; Kishimoto H; Takahashi Y; Urade M; Yoshioka W
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):553-6. PubMed ID: 7887648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
    Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
    Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT].
    Fukunaga H; Katsumi M; Aoki Y; Oka S; Konishi R; Yukawa H; Kawaguchi T; Tamaki Y; Takifuji K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2735-9. PubMed ID: 3115184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
    Suzuki M; Sekiguchi I; Ohwada M; Tamada T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].
    Takashima S; Tomita F; Saito H; Gotoda H; Kinami Y; Miyazaki I; Yamaguchi A
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2315-24. PubMed ID: 1929450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
    Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in rats.
    Kobuchi S; Ito Y; Takamatsu D; Sakaeda T
    Eur J Pharm Sci; 2018 Oct; 123():452-458. PubMed ID: 30077713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.